Lastly, when stratifying according to post-operative outcome, non-recurrence patients exhibited higher levels of infiltrating effector Ig+ IL-10- plasma cells which likely function to augment anti-cancer effector T cell responses, and directly mediate tumour cell death via antibody-dependent mechanisms. This evidence concerns the gene IL10 and neoplasm.